Home/Filings/4/0000950170-25-013471
4//SEC Filing

Savitz Ryan 4

Accession 0000950170-25-013471

CIK 0001690585other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:18 PM ET

Size

5.5 KB

Accession

0000950170-25-013471

Insider Transaction Report

Form 4
Period: 2025-02-03
Savitz Ryan
CFO & CBO
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-03+150,000150,000 total
    Exercise: $22.07Exp: 2035-02-02Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after January 1, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Documents

1 file

Issuer

Dianthus Therapeutics, Inc. /DE/

CIK 0001690585

Entity typeother

Related Parties

1
  • filerCIK 0001992324

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:18 PM ET
Size
5.5 KB